|Outcome||Relative effect 95%CI||LoD||Trt. better when||I2||k (RCT/OBS)||Bayesian probability||Overall ROB||Publication bias||Degree of certainty||Endpoint importance||Published MA|
|deaths||0.97 [0.46, 2.04]||< 1||0%||1 study (1/-)||53.2 %||some concern||not evaluable||moderate||crucial||-|
|clinical deterioration||0.89 [0.42, 1.92]||< 1||0%||1 study (1/-)||61.3 %||some concern||not evaluable||moderate||important||-|
|death or ventilation||0.97 [0.62, 1.52]||< 1||0%||1 study (1/-)||55.3 %||some concern||not evaluable||moderate||important||-|
LoD: level of demonstration ( demonstrated, suggested, inconclusive, safety concerns);
Bayesian probability: Bayesian posterior probability of treatment effect (computed with a noninformative prior); ROB: risk of bias; k: number of studies; published MA: number of published meta-analysis on the same topic; degree of certainty adapted from GRADE. Trt. better when: indicates when the relative treatment effect shows that the studied treatment is better than control.